Conflict of interest
Pierre
Pau Montesinos has served as a consultant for Agios, Astellas, Celgene, Daiichi Sankyo, Forma Therapeutics, Glycomimetics, and Tolero Pharmaceutical; has been an advisor for AbbVie, Astellas, Celgene, Daiichi Sankyo, Incyte, Janssen, Karyopharm, Novartis, Pfizer, Sanofi, and Teva; has received research funding from AbbVie, Astellas, Celgene, Daiichi Sankyo, Janssen, Karyopharm, Novartis, Pfizer, and Teva; and has participated in speakers bureau for AbbVie, Astellas, Celgene, Daiichi Sankyo, Incyte, Janssen, Novartis, Pfizer, Sanofi, and Teva. Vamsi Kota has served as a consultant for Novartis and Pfizer; and has received research funding from Incyte. Joseph Brandwein has received honoraria from AbbVie, Amgen, Astellas, Bristol Myers Squibb, Jazz, Pfizer, Roche, and Taiho. Pierre Bousset, Rebecca J. Benner, Erik Vandendries, and Ying Chen are employees of Pfizer and own stock in Pfizer. Mary Frances McMullin has been an advisor for AbbVie, Bristol Myers Squibb, Celgene, and Novartis; has received research funding from AOP Health and Bristol Myers Squibb; and has participated in speakers bureau for AOP Health and Novartis.